News About: Pharm. Industry
Pfizer Korea seeks its own sales force for combined product portfolio
As Hank McKinnell, chairman and chief executive officer of Pfizer Inc, said that its merger plan with Pharmacia Corporation will close during April of 2003, Pfizer Korea and Pharmacia Korea are stepping up their negot...
Drug advertising activities slow down due to recession.
The drug advertising activities showed under strict controls mainly due to the current economic recession and the government's drug price slashes.
The KPMA report shows the number of drug advertising preview durin...
Upper class drug companies targeting at 100 Billion Won of sales.
100 billion won of the sales is the most attractive target for most of ambitious drug companies to put their ultimate goals this year. It also implies a symbolic number for the upper class drug companies to pursue, in...
Drug makers of renowned brand items carve out bigger market share
Under the 80:20 rule originated from Vilfredo Pareto that a minority of input produces the majority of results, leading pharmaceutical manufacturers have witnessed a sharp increase of more than 15 percent in their mar...
Drug exports on the rising trend.
The drug exports in Jan. and Feb. this year rose significantly compared to the same period last year, showing a bright perspective.
According to the Korea Trade data the drug export in Feb. this year amounted to ab...
Fluoroquinolone Factive acquires approval from US FDAAn antibiotic "Factive" developed by a local drug manufacturer has obtained an approval from the US FDA for the first time in Korea.
LG Life Sciences said recently that Facti... |
Additional indications of Factive probable
LG Life Sciences' Factive has received an approval letter from the US FDA as treatment against community-acquired pneumonia and acute exacerbation of chronic bronchitis, and penicillin-resistant S.pneumoniae (PRSP), e...
Handok-Aventis Pharma launches anti-rheumatic drug "Arava"Handok-Aventis Pharma has newly launched Arava (leflunomide), a new disease-modifying anti-rheumatic drug (DMARD) that reduces inflammation and slows disease progression of rheu... |
Upward momentum of pharmaceutical firms shares likely to continue in April
Market analysts say that with increasing optimism on the possible commercialization of new drugs, combined with a foreign investors' buying spree, the index of pharmaceutical firms rose 3.07 percent in Februar...
Some drug company stocks rising due to SARS.
Amid a global panic with SARS breakout from the Southern China and the rumor that the plague also already landed in Korea, acute fears rapidly spreaded across the whole nation, in the meanwhile, causing some drug comp...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
